• In the media
  • Small companies bear large burden of developi...
Media - published on 10 Jun 2021

Small companies bear large burden of developing superbug treatments – report

Kristen Hallam for S&P Global Market Intelligence writes about the newest report from the Access to Medicine Foundation's Antimicrobial Resistance Benchmark. 

Get in touch

Back to top |